DR. BRUCE H SAIDMAN MD NPI 1053337295

NPI Details

DR. Bruce H Saidman, MD is a hematology and oncology internal medicine in Kingston, PA with 41 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Bruce H Saidman, MD NPI is 1053337295. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1984

The provider's business location address is:

382 PIERCE ST
KINGSTON, PA
ZIP 18704-535
Phone: (570) 288-7231

The NPI 1053337295 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Bilirubin level, direct (HCPCS:82248)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection or infusion into a vein or artery for therapy, prevention, or diagnosis (HCPCS:96379)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Magnesium level (HCPCS:83735)
• Unclassified drugs (HCPCS:J3490)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood creatinine level (HCPCS:82565)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Urinalysis, manual test (HCPCS:81002)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 7/14/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.